DAS
TEVA icon

Diversify Advisory Services’s Teva Pharmaceuticals TEVA Stock Holding History

Diversify Advisory Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,294
Closed -$160K – 867
2025
Q1 		$160K Sell
10,294
-10,061
-49% -$180K 0.01% 621
2024
Q4 		$426K Buy
20,355
+496
+2% +$9.02K 0.02% 397
2024
Q3 		$365K Buy
19,859
+9,693
+95% +$170K 0.02% 452
2024
Q2 		$161K Sell
10,166
-4
-0% -$62 0.01% 612
2024
Q1 		$141K Buy
+10,170
New +$128K 0.01% 619

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Diversify Advisory Services's TEVA Position: Q2 2025 in Review

Diversify Advisory Services sold out of Teva Pharmaceuticals (TEVA) in Q2 2025, closing a stake of 10,294 shares — an estimated $160K sold.

Diversify Advisory Services first reported a position in TEVA in Q1 2024 and held it in 5 quarters. The position peaked at $426K in Q4 2024. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2025.

  • Diversify Advisory Services reported no remaining Teva Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Diversify Advisory Services sold 10,294 Teva Pharmaceuticals shares in Q2 2025, an estimated $160K.
  • Diversify Advisory Services first reported a position in Teva Pharmaceuticals in Q1 2024 and held it in 5 quarters.
  • Diversify Advisory Services's Teva Pharmaceuticals position peaked at $426K in Q4 2024.
  • 539 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2025.

Based on Diversify Advisory Services's 13F filing for Q2 2025, filed 14 Aug 2025.